9th Nov 2020 10:59
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 06 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
3,056,621 | 2.37% | 686,366 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
366,484 | 0.28% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
3,423,105 | 2.66% | 1,425,371 | 1.11% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 191.8300 USD |
Purchase | 10 | 191.4055 USD |
Purchase | 11 | 192.4200 USD |
Purchase | 61 | 191.7878 USD |
Purchase | 131 | 192.1469 USD |
Purchase | 283 | 191.4577 USD |
Purchase | 477 | 189.7306 USD |
Purchase | 544 | 191.1123 USD |
Purchase | 546 | 192.1560 USD |
Purchase | 605 | 192.2027 USD |
Purchase | 619 | 190.1887 USD |
Purchase | 673 | 191.3072 USD |
Purchase | 1,022 | 191.9791 USD |
Purchase | 1,275 | 192.2763 USD |
Purchase | 2,205 | 191.2562 USD |
Purchase | 2,638 | 191.9914 USD |
Purchase | 2,903 | 190.9737 USD |
Purchase | 3,408 | 191.6682 USD |
Purchase | 3,834 | 192.1700 USD |
Purchase | 3,847 | 191.8074 USD |
Purchase | 4,570 | 191.3708 USD |
Purchase | 7,677 | 192.1561 USD |
Purchase | 15,240 | 191.4469 USD |
Purchase | 16,760 | 191.0991 USD |
Sale | 1 | 189.7900 USD |
Sale | 2 | 191.8450 USD |
Sale | 8 | 192.0538 USD |
Sale | 13 | 191.9292 USD |
Sale | 20 | 192.5467 USD |
Sale | 52 | 187.9400 USD |
Sale | 139 | 192.3424 USD |
Sale | 400 | 192.0125 USD |
Sale | 465 | 189.6227 USD |
Sale | 534 | 191.0377 USD |
Sale | 600 | 192.1550 USD |
Sale | 600 | 191.0066 USD |
Sale | 657 | 191.2733 USD |
Sale | 2,065 | 190.9939 USD |
Sale | 2,586 | 191.0190 USD |
Sale | 3,691 | 192.1700 USD |
Sale | 7,678 | 192.1561 USD |
Sale | 17,051 | 191.1766 USD |
Sale | 32,578 | 191.5615 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 9 Nov 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201109005518/en/
Copyright Business Wire 2020
Related Shares:
Barclays